Evaluation of A PCR-Based Universal Heteroduplex Generator Assay As A Tool for Rapid Detection of Multidrug-Resistant Mycobacterium tuberculosis in Peru

Journal of Clinical Microbiology

Volumn 41, Issue 12, 2003, Pages 5774-5777

  Mayta, Holger ^a,b   Gilman, Robert H ^a,b,c,i   Arenas, Fanny ^b   Valencia, Teresa ^b   Caviedes, Luz ^b   Montenegro, Sonia H ^g   Ticona, Eduardo ^d   Ortiz, Jaime ^e   Chumpitaz, Rosa ^b   Evans, Carlton A ^f   Williams, Diana L ^h  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c ASOCIACIÓN BENÉFICA PRISMA   (Peru)

^d HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^e Maria Auxiliadora Hospital   (Peru)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g OCHSNER MEDICAL CENTER   (United States)

^h U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; DEVELOPING COUNTRY; ENDEMIC DISEASE; GENE MUTATION; HETERODUPLEX ANALYSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 10744223420     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.12.5774-5777.2003     Document Type: Article

References (28)

1. Barnes, P., A. B. Bloch, P. T. Davidson, and D. E. Snider, Jr. 1991. Tuberculosis in patients with immunodeficiency virus infection. N. Engl. J. Med. 324:1644-1650.
2. Becerra, M. C., J. Freeman, J. Bayona, S. S. Shin, J. Y. Kim, J. J. Furin, B. Werner, A. Sloutsky, R. Timperi, M. E. Wilson, M. Pagano, and P. E. Farmer. 2000. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Int. J. Tuber. Lung Dis. 4:108-114.
3. Behr, M. A., S. A. Warren, H. Salamon, P. C. Hopewell, A. Ponce de Leon, C. L. Daley, and P. M. Small. 1999. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 353:444-449.
4. Caviedes, L., T. S. Lee, R. H. Gilman, P. Sheen, E. Spellman, E. H. Lee, D. E. Berg, and S. Montenegro-James. 2000. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J. Clin. Microbiol. 38:1203-1208.
5. Caws, M., and F. A. Drobniewski. 2001. Molecular techniques in the diagnosis of Mycobacterium tuberculosis and the detection of drug resistance. Ann. N. Y. Acad. Sci. 953:138-145.
6. Cole, S. T., and A. Telenti. 1995. Drug resistance in Mycobacterium tuberculosis. Eur. Res. J. 8:701S-13S.
7. Dalovisio, J. R., S. Montenegro-James, S. A. Kemmerly, C. F. Genre, R. Chambers, D. Greer, G. A. Pankey, D. M. Failla, K. G. Haydel, L. Hutchinson, M. F. Lidney, B. M. Nunez, A. Praba, K. D. Eisenach, and E. S. Cooper. 1996. Comparison of the amplified Mycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens. Clin. Infect. Dis. 23:1099-1106.
8. Farmer, P. 2001. DOTS and DOTS-plus: not the only answer. Ann. N. Y. Acad. Sci. 953:165-184.
9. Fluit, A. C., M. R. Visser, and F. J. Schmitz. 2001. Molecular detection of antimicrobial resistance. Clin. Microbiol. Rev. 14:836-871.
10. Franchi, L. M., R. I. Cama, R. H. Gilman, S. Montenegro-James, and P. Sheen. 1998. Detection of Mycobacterium tuberculosis in nasopharyngeal aspirate samples in children. Lancet 352:1681-1682.
11. Franzblau, S. G., R. S. Witzig, J. C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M. T. Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson, and R. H. Gilman. 1998. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J. Clin. Microbiol. 36:362-366.
12. Frieden, T. R., T. Sterling, A. Pablos-Mendez, J. O. Kilburn, G. M. Cauthen, and S. W. Dooley. 1993. The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med. 328:521-526.
13. Goyal, M., R. J. Shaw, D. K. Banerjee, R. J. Coker, B. D. Robertson, and D. B. Young. 1997. Rapid detection of multidrug-resistant tuberculosis. Eur. Respir. J. 10:1120-1124.
14. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. U.S. Department of Health and Human Services. Center for Disease Control, Atlanta, Ga.
15. Kochi, A., B. Vareldzis, and K. Styblo. 1993. Multidrug-resistant tuberculosis and its control. Res. Microbiol. 144:104-110.
16. Montenegro, S. H., R. H. Gilman, P. Sheen, R. Cama, L. Caviedes, T. Hopper, R. Chambers, and R. A. Oberhelman. 2003. Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin. Infect. Dis. 36:16-23.
17. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nun. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-Intemational Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 338:1641-1649.
18. Park, W. G., W. R. Bishai, R. E. Chaisson, and S. E. Dorman. 2002. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J. Clin. Microbiol. 40:4750-4752.
19. Pozniak, A. 2001. Multidrug-resistant tuberculosis and HIV infection. Ann. N. Y. Acad. Sci. 953:192-198.
20. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:3-29.
21. Singh, N. P., and S. C. Parija. 1998. The value of fluorescence microscopy of auramine stained sputum smears for the diagnosis of pulmonary tuberculosis. Southeast Asian J. Trop. Med. Public Health 29:860-863.
22. Soini, H., and J. M. Musser. 2001. Molecular diagnosis of mycobacteria. Clin. Chem. 47:809-814.
23. Williams, D. L., L. Spring, T. P. Gillis, M. Salfinger, and D. H. Persing. 1998. Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. Clin. Infect. Dis. 26:446-450.
24. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, E. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.
25. Williams, D. L., C. Limbers, L. Spring, S. Jayachandra, and T. Gillis. 1996. PCR-heteroduplex detection of rifampin-resistant Mycobacterium tuberculosis, p. 122-129. In D. Persing (ed.), PCR protocols for emerging infectious diseases. ASM Press, Washington, D.C.
26. World Health Organization. 1994. WHO Tuberculosis Program: framework for effective tuberculosis control. World Health Organization, Geneva, Switzerland.
27. World Health Organization. 1998. Anti-tuberculosis drug resistance in the world. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1994-1997. World Health Organization, Geneva, Switzerland.
28. World Health Organization. 2001. Global tuberculosis control. World Health Organization, Geneva, Switzerland.